Artigos de revistas sobre o tema "Minimal pharmacophores"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Minimal pharmacophores".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Mortier, Jérémie, Pratik Dhakal e Andrea Volkamer. "Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces". Molecules 23, n.º 8 (6 de agosto de 2018): 1959. http://dx.doi.org/10.3390/molecules23081959.
Texto completo da fontePetrikaite, Vilma, Eduardas Tarasevišius e Alvydas Pavilonis. "New ethacridine derivatives as the potential antifungal and antibacterial preparations". Medicina 43, n.º 8 (11 de agosto de 2007): 657. http://dx.doi.org/10.3390/medicina43080084.
Texto completo da fonteSpasov, Alexander, Irina Ovchinnikova, Olga Fedorova, Yulia Titova, Denis Babkov, Vadim Kosolapov, Alexander Borisov et al. "Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury". Molecules 28, n.º 2 (11 de janeiro de 2023): 741. http://dx.doi.org/10.3390/molecules28020741.
Texto completo da fonteMishra, Pranjali, Muskan Srivastav, Yashveer Gautam, Monal Singh, Neeraj Verma, Deepak S. Kapkoti, Shailendra P. Singh, Anil K. Singh e Devendra P. Rao. "A REVIEW IN CURCUMINOIDS: CHEMISTRY, ANTICANCER ACTIVITY AND FUTURE PROSPECTS". INDIAN DRUGS 61, n.º 05 (28 de maio de 2024): 7–23. http://dx.doi.org/10.53879/id.61.05.14041.
Texto completo da fonteMaatuf, Yossi, Matan Geron e Avi Priel. "The Role of Toxins in the Pursuit for Novel Analgesics". Toxins 11, n.º 2 (23 de fevereiro de 2019): 131. http://dx.doi.org/10.3390/toxins11020131.
Texto completo da fonteWermelinger, Guilherme Freimann, Lucas Rubini, Anna Carolina Carvalho da Fonseca, Gabriel Ouverney, Rafael P. R. F. de Oliveira, Acácio S. de Souza, Luana S. M. Forezi, Gabriel Limaverde-Sousa, Sergio Pinheiro e Bruno Kaufmann Robbs. "A Novel MDM2-Binding Chalcone Induces Apoptosis of Oral Squamous Cell Carcinoma". Biomedicines 11, n.º 6 (14 de junho de 2023): 1711. http://dx.doi.org/10.3390/biomedicines11061711.
Texto completo da fonteBourne, Yves, Gerlind Sulzenbacher, Laurent Chabaud, Rómulo Aráoz, Zoran Radić, Sandrine Conrod, Palmer Taylor, Catherine Guillou, Jordi Molgó e Pascale Marchot. "The Cyclic Imine Core Common to the Marine Macrocyclic Toxins Is Sufficient to Dictate Nicotinic Acetylcholine Receptor Antagonism". Marine Drugs 22, n.º 4 (27 de março de 2024): 149. http://dx.doi.org/10.3390/md22040149.
Texto completo da fonteCaldas Lopes, Eloisi, Shieh Jae-Hung, Srikanth Ambati, Su Tsann-Long, Fabian Correa, Elizabeth Peguero e Malcolm A. S. Moore. "Novel Alkylating Agent, Ureidomustine Exhibit Pre-Clinical Efficacy in B-Cell Lymphoma with Minimal Dose-Limiting Myelotoxicity". Blood 126, n.º 23 (3 de dezembro de 2015): 1556. http://dx.doi.org/10.1182/blood.v126.23.1556.1556.
Texto completo da fonteVawhal, Pallavi Kishor, Shailaja B. Jadhav, Sumit Kaushik, Kahnu Charan Panigrahi, Chandan Nayak, Humaira Urmee, Sharuk L. Khan et al. "Coumarin-Based Sulfonamide Derivatives as Potential DPP-IV Inhibitors: Pre-ADME Analysis, Toxicity Profile, Computational Analysis, and In Vitro Enzyme Assay". Molecules 28, n.º 3 (19 de janeiro de 2023): 1004. http://dx.doi.org/10.3390/molecules28031004.
Texto completo da fonteRobertson, Gregory T., Eric J. Bonventre, Timothy B. Doyle, Qun Du, Leonard Duncan, Timothy W. Morris, Eric D. Roche, Dalai Yan e A. Simon Lynch. "In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci". Antimicrobial Agents and Chemotherapy 52, n.º 7 (julho de 2008): 2324–34. http://dx.doi.org/10.1128/aac.01651-07.
Texto completo da fonteCheng, Jeffrey, Enming Xing, Shabber Mohammed, Emma Montgomery, Lauren Granchie, Christopher Coss e Pui-Kai Li. "Abstract 3106: Design, synthesis, and screening of niclosamide analogs as androgen receptor degraders for hepatocellular carcinoma". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3106. http://dx.doi.org/10.1158/1538-7445.am2023-3106.
Texto completo da fonteAlhadrami, Hani A., Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy e Mostafa E. Rateb. "Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor". Pharmaceuticals 14, n.º 6 (5 de junho de 2021): 541. http://dx.doi.org/10.3390/ph14060541.
Texto completo da fonteOsborne, Joseph, Naveed Hassan Akhtar, Shankar Vallabhajosula, Anastasia Nikolopoulou, Kevin P. Maresca, Shawn M. Hillier, John L. Joyal et al. "Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC)." Journal of Clinical Oncology 30, n.º 5_suppl (10 de fevereiro de 2012): 173. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.173.
Texto completo da fonteHall, Ronald G., Jotam Pasipanodya, William C. Putnam, John Griswold, Sharmila Dissanaike, Raja Reddy Kallem, Vindhya Edpuganti e Indhumathy Subramaniyan. "1319. Pharmacokinetics of Ceftolozane/Tazobactam in Patients with Burns". Open Forum Infectious Diseases 7, Supplement_1 (1 de outubro de 2020): S670—S671. http://dx.doi.org/10.1093/ofid/ofaa439.1501.
Texto completo da fonteSchlitzer, Martin, Labaniel Rodriguez e Peter F. Kador. "Synthesis of potential aldose reductase inhibitors based on minimal pharmacophore requirements". Journal of Pharmacy and Pharmacology 53, n.º 6 (junho de 2001): 831–39. http://dx.doi.org/10.1211/0022357011776180.
Texto completo da fontePapke, Roger L., Kinga Chojnacka e Nicole A. Horenstein. "The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor". Journal of Pharmacology and Experimental Therapeutics 350, n.º 3 (2 de julho de 2014): 665–80. http://dx.doi.org/10.1124/jpet.114.215236.
Texto completo da fonteMagnin, David R., Prakash C. Taunk, James G. Robertson, Aiying Wang, Jovita Marcinkeviciene, Mark S. Kirby e Lawrence G. Hamann. "Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1". Bioorganic & Medicinal Chemistry Letters 16, n.º 6 (março de 2006): 1731–34. http://dx.doi.org/10.1016/j.bmcl.2005.11.098.
Texto completo da fonteJohnston, Alexis, e Adegboyega K. Oyelere. "Abstract 4492: Deferiprone optimization for the treatment of triple-negative breast cancer". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 4492. http://dx.doi.org/10.1158/1538-7445.am2024-4492.
Texto completo da fonteCruz, María del Carmen, María Salazar, Yésica Garciafigueroa, Dolores Hernández, Francisco Díaz, Germán Chamorro e Joaquín Tamariz. "Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α-Asarone with Minimal Pharmacophore Features". Drug Development Research 60, n.º 3 (3 de outubro de 2003): 186–95. http://dx.doi.org/10.1002/ddr.10281.
Texto completo da fonteBjij, Imane, Pritika Ramharack, Shama Khan, Driss Cherqaoui e Mahmoud E. S. Soliman. "Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling". Molecules 24, n.º 17 (28 de agosto de 2019): 3125. http://dx.doi.org/10.3390/molecules24173125.
Texto completo da fonteWood, Daniel J., J. Daniel Lopez-Fernandez, Leanne E. Knight, Islam Al-Khawaldeh, Conghao Gai, Shengying Lin, Mathew P. Martin et al. "FragLites—Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation". Journal of Medicinal Chemistry 62, n.º 7 (12 de março de 2019): 3741–52. http://dx.doi.org/10.1021/acs.jmedchem.9b00304.
Texto completo da fonteOstash, Bohdan, Emma Doud e Victor Fedorenko. "The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases". Biological Chemistry 391, n.º 5 (1 de maio de 2010): 499–504. http://dx.doi.org/10.1515/bc.2010.053.
Texto completo da fonteGozalbes, Rafael, Silvia Mosulén, Rodrigo J. Carbajo e Antonio Pineda-Lucena. "Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors". Journal of Computer-Aided Molecular Design 23, n.º 8 (7 de maio de 2009): 555–69. http://dx.doi.org/10.1007/s10822-009-9269-0.
Texto completo da fonteLadouceur, Gaétan, Dale E. Mais, Joseph A. Jakubowski, Barbara G. Utterback e David W. Robertson. "Structural homologies among thromboxane (TXA2) receptor antagonists: Minimal pharmacophoric requirements for high affinity interaction with TXA2 receptors". Bioorganic & Medicinal Chemistry Letters 1, n.º 3 (janeiro de 1991): 173–78. http://dx.doi.org/10.1016/s0960-894x(01)80794-0.
Texto completo da fonteMittal, Ravi K., e Priyank Purohit. "Quinoline-3-carboxylate Derivatives: A New Hope as an Antiproliferative Agent". Anti-Cancer Agents in Medicinal Chemistry 20, n.º 16 (5 de novembro de 2020): 1981–91. http://dx.doi.org/10.2174/1871520620666200619175906.
Texto completo da fonteKhomutov, Maxim A., Fabio Giovannercole, Laura Onillon, Marija V. Demiankova, Byazilya F. Vasilieva, Arthur I. Salikhov, Sergey N. Kochetkov, Olga V. Efremenkova, Alex R. Khomutov e Daniela De Biase. "A Desmethylphosphinothricin Dipeptide Derivative Effectively Inhibits Escherichia coli and Bacillus subtilis Growth". Biomolecules 13, n.º 10 (26 de setembro de 2023): 1451. http://dx.doi.org/10.3390/biom13101451.
Texto completo da fonteDemeter, David A., Herschel J. R. Weintraub e James J. Knittel. "The Local Minima Method (LMM) of Pharmacophore Determination: A Protocol for Predicting the Bioactive Conformation of Small, Conformationally Flexible Molecules". Journal of Chemical Information and Computer Sciences 38, n.º 6 (novembro de 1998): 1125–36. http://dx.doi.org/10.1021/ci980404z.
Texto completo da fonteJi, Haitao, Benjamin Z. Stanton, Jotaro Igarashi, Huiying Li, Pavel Martásek, Linda J. Roman, Thomas L. Poulos e Richard B. Silverman. "Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase Inhibitors". Journal of the American Chemical Society 130, n.º 12 (março de 2008): 3900–3914. http://dx.doi.org/10.1021/ja0772041.
Texto completo da fonteRasaeifar, Bahareh, Patricia Gomez-Gutierrez e Juan J. Perez. "New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding". Pharmaceuticals 13, n.º 8 (17 de agosto de 2020): 197. http://dx.doi.org/10.3390/ph13080197.
Texto completo da fonteMartinenghi, Laura Daniela, Rie Jønsson, Torben Lund e Håvard Jenssen. "Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from Cannabis sativa L." Biomolecules 10, n.º 6 (12 de junho de 2020): 900. http://dx.doi.org/10.3390/biom10060900.
Texto completo da fonteEzekiel, Olugbogi A., Arobadade A. Oluwaotbiloba, Balogun A. Samuel, Adelakun G. Oluwatosin, Maduike N. Mary, Fadeju T. Rasheedat, Kayode O. Yetunde et al. "Application of In-silico Methodologies in Exploring the Antagonistic Potential of Trigonella frenum-graecum on Cyclooxygenase-2 (Cox-2) in Cancer Treatment". IPS Journal of Molecular Docking Simulations 2, n.º 1 (15 de setembro de 2023): 26–36. http://dx.doi.org/10.54117/ijmds.v2i1.20.
Texto completo da fonteZapata-Acevedo, César A., e Paul L. A. Popelier. "The IQA Energy Partition in a Drug Design Setting: A Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B) Case Study". Pharmaceuticals 15, n.º 10 (8 de outubro de 2022): 1237. http://dx.doi.org/10.3390/ph15101237.
Texto completo da fonteMa’arif, Burhan, Faisal Akhmal Muslikh, Luqman Alfani Najib, Ria Ramadhani Dwi Atmaja e Meilina Ratna Dianti. "In Silico Antiosteoporosis Activity of 96% Ethanol Extract of Chrysophyllum cainito L. Leaves". Proceedings of International Pharmacy Ulul Albab Conference and Seminar (PLANAR) 1 (5 de dezembro de 2021): 61. http://dx.doi.org/10.18860/planar.v1i0.1460.
Texto completo da fonteMotsilanyane, Andrew Rabontsi, Zimbili Mkhize e Sphelele Sosibo. "Computational Studies for Selected Medicinal Plants against Dolutegravir using Ligand Based Pharmacophore, Molecular Docking, ADMET Predictionsand Molecular Dynamics Simulation". Pakistan Journal of Medical and Health Sciences 16, n.º 1 (30 de janeiro de 2022): 927–36. http://dx.doi.org/10.53350/pjmhs22161927.
Texto completo da fonteFrancesconi, Valeria, Elena Cichero, Evgeny V. Kanov, Erik Laurini, Sabrina Pricl, Raul R. Gainetdinov e Michele Tonelli. "Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies". Pharmaceuticals 13, n.º 11 (14 de novembro de 2020): 391. http://dx.doi.org/10.3390/ph13110391.
Texto completo da fonteMcBride, Molly J., Sarah R. Pope, Kai Hu, C. Denise Okafor, Emily P. Balskus, J. Martin Bollinger e Amie K. Boal. "Structure and assembly of the diiron cofactor in the heme-oxygenase–like domain of the N-nitrosourea–producing enzyme SznF". Proceedings of the National Academy of Sciences 118, n.º 4 (19 de janeiro de 2021): e2015931118. http://dx.doi.org/10.1073/pnas.2015931118.
Texto completo da fonteZhou, Heyang, Niao Yang, Wei Li, Xuemi Peng, Jiaxiao Dong, Yuanying Jiang, Lan Yan, Dazhi Zhang e Yongsheng Jin. "Exploration of Baicalein-Core Derivatives as Potent Antifungal Agents: SAR and Mechanism Insights". Molecules 28, n.º 17 (30 de agosto de 2023): 6340. http://dx.doi.org/10.3390/molecules28176340.
Texto completo da fonteHasan, Md Rifat, Ahad Amer Alsaiari, Burhan Zain Fakhurji, Mohammad Habibur Rahman Molla, Amer H. Asseri, Md Afsar Ahmed Sumon, Moon Nyeo Park, Foysal Ahammad e Bonglee Kim. "Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process". Molecules 27, n.º 13 (29 de junho de 2022): 4169. http://dx.doi.org/10.3390/molecules27134169.
Texto completo da fonteRaghuvanshi, Rinky, e Sandip B. Bharate. "Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review". Current Topics in Medicinal Chemistry 20, n.º 12 (1 de junho de 2020): 1124–35. http://dx.doi.org/10.2174/1568026620666200325110444.
Texto completo da fonteHao, Wenhui, Shiying Che, Jinsheng Li, Jingyi Luo, Wanqiu Zhang, Yang Chen, Zijian Zhao, Hao Wei e Weidong Xie. "Synthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms". Molecules 27, n.º 9 (5 de maio de 2022): 2948. http://dx.doi.org/10.3390/molecules27092948.
Texto completo da fonteTing, Jasmine U., Maria Carmen S. Tan, Vincent Antonio S. Ng, Stephani Joy Y. Macalino, Virgilio C. Linis e Glenn G. Oyong. "Molecular Simulations of Unexplored Philippine Plant Constituents on the Inhibition of the Proinflammatory Marker NF-κB p50 Subunit". Crystals 14, n.º 5 (4 de maio de 2024): 438. http://dx.doi.org/10.3390/cryst14050438.
Texto completo da fonteBranco, Jessica R., Vanessa G. Oliveira, Amanda M. Esteves, Ingrid C. Chipoline, Miriam F. O. Lima, Fernanda C. S. Boechat, Fernando C. da Silva et al. "A Novel Naphthotriazolyl-4-oxoquinoline Derivative that Selectively Controls Breast Cancer Cells Survival Through the Induction of Apoptosis". Current Topics in Medicinal Chemistry 18, n.º 17 (26 de novembro de 2018): 1465–74. http://dx.doi.org/10.2174/1568026618666180821142458.
Texto completo da fonteLomovskaya, Olga, Kirk J. Nelson e Debora Rubio-Aparicio. "727. Potency of the β-Lactamase Inhibitor QPX7728 Is Minimally Affected by KPC Mutations that Reduce Potency of Ceftazidime–Avibactam". Open Forum Infectious Diseases 6, Supplement_2 (outubro de 2019): S326. http://dx.doi.org/10.1093/ofid/ofz360.795.
Texto completo da fonteSokolova, K. V., V. V. Stavytskyi, S. О. Konovalova, O. A. Podpletnya, S. I. Kovalenko e A. P. Avdeenko. "Design and search for prospective diuretics (CA II Inhibitors) among aroylhydrazones of esters quinone oxime using in silico and in vivo methodology". Medicni perspektivi 27, n.º 4 (29 de dezembro de 2022): 27–37. http://dx.doi.org/10.26641/2307-0404.2022.4.271120.
Texto completo da fonteSacco, Antonio, Cinzia Federico, Arianna Giacomini, Cinzia Caprio, Federica Maccarinelli, Katia Todoerti, Vanessa Favasuli et al. "FGF/FGFR Axis-Blockade Leads to Anti-Tumor Activity in Waldenstrom's Macroglobulinemia By Silencing MYD88". Blood 136, Supplement 1 (5 de novembro de 2020): 43–44. http://dx.doi.org/10.1182/blood-2020-136523.
Texto completo da fonteLuthra, Pratibha Mehta, e Nitin Kumar. "Progress and development of C-3, C-6, and N-9 position substituted carbazole integrated molecular hybrid molecules as potential anticancer agents". Mini-Reviews in Medicinal Chemistry 21 (21 de maio de 2021). http://dx.doi.org/10.2174/1389557521666210521221808.
Texto completo da fonteWhitehouse, Rebecca L., Wesam S. Alwan, Olga V. Ilyichova, Ashley J. Taylor, Indu R. Chandrashekaran, Biswaranjan Mohanty, Bradley C. Doak e Martin J. Scanlon. "Fragment screening libraries for the identification of protein hot spots and their minimal binding pharmacophores". RSC Medicinal Chemistry, 2022. http://dx.doi.org/10.1039/d2md00253a.
Texto completo da fonteSingh, Shailja, e Shrawan Kumar Mangawa. "Ferrocene Derivatives as New Generation of Antimalarial Agents: Opportunity or Illusion?" Current Topics in Medicinal Chemistry 23 (28 de fevereiro de 2023). http://dx.doi.org/10.2174/1568026623666230228153114.
Texto completo da fonteKayastha, Forum, Noah B. Herrington, Bandish Kapadia, Anirban Roychowdhury, Nahid Nanaji, Glen E. Kellogg e Ronald B. Gartenhaus. "Novel eIF4A1 inhibitors with anti‐tumor activity in lymphoma". Molecular Medicine 28, n.º 1 (4 de setembro de 2022). http://dx.doi.org/10.1186/s10020-022-00534-0.
Texto completo da fonteRath, Santosh Kumar, Sudip Kumar Mandal, Agnidipta Das, Anindya Bose, Vagish Dwibedi, Paramita Ganguly, Sipra Sarkar, Ranjana Prakash, Biplab Kumar Dey e Sanjeet Mandal. "Hetero Cyclic Compounds in the Treatment of Triple-Negative Breast Cancer". Current Cancer Therapy Reviews 19 (30 de dezembro de 2022). http://dx.doi.org/10.2174/1573394719666221230111838.
Texto completo da fonte